Eminent Domain for Overpriced Drugs

Today on TAP: Exhibit A is the case of the EpiPen. It should cost a few dollars rather than the $600 or more charged by monopolist Viatris.

by

TAP depends on your support

We’ve said it before: The greatest threat to democracy from the media isn’t disinformation, it’s the paywall. When you support The American Prospect, you’re supporting fellow readers who aren’t able to give, and countering the class system for information. Please, become a member, or make a one-time donation, today. Thank you!